OptoGenTech Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $343K

  • Investors
  • 4

OptoGenTech General Information

Description

Developer of implantable stimulators and optogenetic gene therapies designed for optical stimulation of nerve cells. The company's first product focuses on a combination product to restore near-natural hearing in deaf patients, and the medical device integrates micro-scale emitters to stimulate the optogenetically altered auditory nerve, enabling hearing-impaired people to participate in vocal communication in their daily lives and enjoy music.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Friedrichstraße 3-4
  • 37073 Gottingen
  • Germany
+49 015560
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Corporate Office
  • Friedrichstraße 3-4
  • 37073 Gottingen
  • Germany
+49 015560

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OptoGenTech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 01-Jul-2022 $343K Completed Product Development
3. Accelerator/Incubator 28-Oct-2021 Completed Product Development
2. University Spin-Out 01-Jan-2019 $1.71M Completed Product Development
1. Accelerator/Incubator 01-Feb-2018 $1.71M $1.71M Completed Product Development
To view OptoGenTech’s complete valuation and funding history, request access »

OptoGenTech Patents

OptoGenTech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026027504-A1 Light guide and optical implant having a light guide Pending 29-Jul-2024
DE-102024121523-A1 Optical fiber and optical cochlear implant with optical fiber Pending 29-Jul-2024
EP-4454701-A1 Method for operating an optical cochlear implant and optical cochlear implant for carrying out the method Pending 24-Apr-2023
WO-2024223487-A1 Method for the operation of an optical cochlea implant and optical cochlea implant for performing the method Inactive 24-Apr-2023
US-20260137954-A1 Optical cochlea implant Pending 24-Apr-2023 A61N5/0622
To view OptoGenTech’s complete patent history, request access »

OptoGenTech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OptoGenTech Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
KIT Institute of Microstructure Technology University Minority
SNIC Accelerator Accelerator/Incubator
University Medical Center of Göttingen Corporation
Photonik Inkubator Accelerator/Incubator Minority
To view OptoGenTech’s complete investors history, request access »

OptoGenTech FAQs

  • When was OptoGenTech founded?

    OptoGenTech was founded in 2017.

  • Where is OptoGenTech headquartered?

    OptoGenTech is headquartered in Gottingen, Germany.

  • What is the size of OptoGenTech?

    OptoGenTech has 3 total employees.

  • What industry is OptoGenTech in?

    OptoGenTech’s primary industry is Therapeutic Devices.

  • Is OptoGenTech a private or public company?

    OptoGenTech is a Private company.

  • What is OptoGenTech’s current revenue?

    The current revenue for OptoGenTech is .

  • How much funding has OptoGenTech raised over time?

    OptoGenTech has raised $2.05M.

  • Who are OptoGenTech’s investors?

    KIT Institute of Microstructure Technology, SNIC Accelerator, University Medical Center of Göttingen, and Photonik Inkubator have invested in OptoGenTech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process